UBS NEW ISSUE / FINAL TERMS: CHF PERLES Plus on worst of ABB / Actelion / Novartis (Valor 26195699) Dienstag, 02. Dezember 2014 - 14:12

UBS issued a new CHF PERLES Plus on worst of ABB / Actelion / Novartis directly in the secondary market.

For further information please have a look at the attached termsheet.

Kind regards,